Bonk Inc

Bonk Inc’s 2025 10‑K reveals a bold pivot from health drinks to plant‑based energy and DeFi, with a reverse split, new CFO, and fresh growth strategy.

Bonk Inc., a Nasdaq‑listed non‑alcoholic beverage innovator, struggles with steep stock declines and a negative P/E, yet its health‑focused detox drink offers a unique market opportunity amid rising wellness demand.

Bonk Inc’s steep stock plunge and negative P/E spark investor doubts, revealing fragile finances behind its “Safety Shot” detox drinks and limited U.S. focus.

Bonk Inc. stock falls from $42 to $2.75, negative P/E and low P/B reveal deep losses and market uncertainty in the consumer staples sector.

Bonk Inc. shifts 51% of fees to BNKK token buy‑backs, boosting supply control and liquidity while launching a regulated ETP on SIX Swiss to attract institutional investors.

Bonk Inc’s stock slumps to $0.21 amid a negative PE ratio, but its niche non‑alcoholic detox drinks offer growth potential in the health‑conscious market.

Bonk Inc.’s stock price has plummeted to $0.23, sparking investor concerns about the company’s financial instability and negative earnings, despite its innovative product line in the non-alcoholic beverage market.